BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jung HR, Jo S, Jeon MJ, Lee H, Chu Y, Lee J, Kim E, Song GY, Jung C, Kim H, Lee S. Development of Small-Molecule STING Activators for Cancer Immunotherapy. Biomedicines 2021;10:33. [PMID: 35052713 DOI: 10.3390/biomedicines10010033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Niu J, Bai H, Li Z, Gao Y, Zhang Y, Wang X, Yang Y, Xu Y, Geng M, Xie Z, Zhou B. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration. European Journal of Medicinal Chemistry 2022;238:114482. [DOI: 10.1016/j.ejmech.2022.114482] [Reference Citation Analysis]
2 Kang J, Wu J, Liu Q, Wu X, Zhao Y, Ren J. Post-Translational Modifications of STING: A Potential Therapeutic Target. Front Immunol 2022;13:888147. [DOI: 10.3389/fimmu.2022.888147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]